Complete re-branding initiative including website, email marketing, technical communications and client presentations for Outcome Capital, a healthcare and technology-focused investment bank.
A series of initiatives to assess market potential, develop market entry strategy and launch new product line for Cisbio, a life sciences provider of high throughput reagents and services.
Coordination and execution of marketing for MaxCyte, a provider of an enabling technology for cell engineering within the fields of cell & gene therapy, biotherapeutic development and small molecule development.
Strategically expand marketing activities including new product launches for Hepregen, a provider of an innovative technology for cell-based toxicity screening.
Coordination and execution of marketing including re-branding for Alpaqua Engineering, a provider of automation products for next generation sequencing and high throughput genomics.